1. PaTH Forward: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial with an Open-Label Extension, Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Subcutaneously Daily in Adults with Hypoparathyroidism

2. A Randomized, Double-blind, Placebo-controlled, Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of Abaloparatide-SC for the Treatment of Men with Osteoporosis

3. SHP634-404 An open label study investigating the Safety and Efficacy of rhPTH-1-84 in subjects with hypoparathyroidism

4. SHP634-401 Study of the Effect of Recombinant Human Parathyroid Hormone [rhPTH(1-84)] on Symptoms Improvement and Metabolic Control Among Adults With Hypoparathyroidism

5. Efficacy of low dose Denosumab in maintaining bone mineral density in postmenopausal women with osteoporosis: a real world, prospective observational study

6. (PARADIGM) Physicians Advancing Disease Knowledge in Hypoparathyroidism): A natural history registry for patients with chronic hypoparathyroidism

7. Canadian National Hypoparathyroidism Registry- Observational prospective study of hypoparathyroidism

8. Osteoporosis Treatment Rate Following Hip Fracture in a Community Hospital: A retrospective chart review 

9. Canadian Registry for Atypical Femur Fractures

10. Hypophosphatasia (HPP)

11.  X-linked Hypophosphatemia Disease Monitoring Program – (XLH-DMP)

12. CALIBRATE: A Phase 3 Open-Label Study Evaluating the Efficacy and Safety of EncaleretCompared to Standard of Care in Adolescent and Adult Participants withAutosomal Dominant Hypocalcemia Type 1 (ADH1)

13. AUTOSOMAL DOMINANT HYPOCALCEMIA TYPES 1 AND 2 (ADH1/2) DISEASE MONITORING STUDY (DMS)

14. PaTHway TRIAL: A Phase 3, Multicenter, Randomized, Double-Blind,Placebo-Controlled, Parallel Group Trial, with an Open-Label Extension,Investigating the Safety, Tolerability and Efficacy of TransCon PTHAdministered Subcutaneously Daily in Adults with Hypoparathyroidism